PGT testing in India helps fertility specialists examine specific genetic features of embryos created through in vitro fertilisation (IVF) before an embryo is transferred to the uterus. Depending on the patient's medical history, the test can assess chromosome abnormalities, identify certain inherited genetic conditions or examine specific structural chromosome changes.
For couples considering infertility treatment, PGT may be worth discussing when there is a known genetic condition in the family, a chromosome rearrangement or another clinical reason to investigate embryo genetics. However, it is not necessary for every IVF patient, and a reassuring result cannot guarantee pregnancy or the birth of a healthy baby.
India has fertility centres that offer IVF and genetic testing services. Before choosing a hospital, patients should understand which type of PGT they need, how the procedure works, what the results can tell them and how much the complete treatment may cost.
Preimplantation genetic testing (PGT) is a laboratory procedure used to examine selected genetic characteristics of embryos produced through IVF. A trained embryologist collects a small sample of cells from a suitable embryo, and a genetic laboratory analyses the sample for a particular chromosome abnormality or genetic condition.
The results help doctors assess which embryos may be considered for transfer. The test does not examine every cell in the embryo, nor does it detect every possible genetic or developmental condition.
There are three main types of PGT:
Each test serves a different purpose. A fertility specialist should recommend the appropriate option based on medical findings rather than treating PGT as a routine requirement for every IVF cycle.
The reasons for considering PGT testing in India depend on the patient's reproductive history and genetic risk. Testing may provide useful information when the results could influence embryo selection or reproductive planning.
If one or both prospective parents carry a disease-causing genetic variant, PGT-M may help identify embryos affected by the particular condition being tested. The approach depends on the inheritance pattern and whether a reliable test can be developed.
Some people carry balanced chromosome rearrangements without having noticeable health problems. However, these rearrangements may increase the chance of producing embryos with an unbalanced amount of chromosome material. PGT-SR may be considered in such cases.
PGT-A examines whether the sampled embryo cells appear to contain the expected number of chromosomes. A specialist may discuss this test based on age, previous pregnancy outcomes and the overall IVF plan.
However, PGT-A does not improve the chance of a live birth for every IVF patient. Its potential benefits should be weighed against its limitations and additional cost.
Some pregnancy losses are associated with chromosome abnormalities. When a patient has experienced repeated losses, the fertility specialist may review the medical history and decide whether genetic investigations could help explain the situation.
PGT is not automatically required after recurrent miscarriage. The decision should follow an appropriate evaluation.
Understanding the differences between the tests helps patients ask more relevant questions during a fertility consultation.
| Test | What it examines | When it may be considered |
|---|---|---|
| PGT-A | Chromosome number | When chromosome-number assessment may be clinically useful |
| PGT-M | A specific disease-causing gene variant | When there is a known inherited genetic condition |
| PGT-SR | Certain structural chromosome rearrangements | When a parent carries a relevant chromosome rearrangement |
PGT-A in India refers to preimplantation genetic testing for aneuploidy. Aneuploidy means that a cell has an abnormal number of chromosomes.
Human cells usually contain 46 chromosomes. An embryo with an abnormal chromosome number may have a lower chance of developing successfully, although the effects depend on the particular chromosome and the nature of the abnormality.
PGT-A involves testing a small sample of cells from an embryo, commonly at the blastocyst stage.
A fertility specialist may discuss PGT-A when reviewing:
One limitation is that the biopsy represents only a small part of the embryo. Some embryos contain cells with different chromosome patterns, a condition called mosaicism. Results can therefore be difficult to interpret in certain cases.
PGT-A also cannot guarantee implantation, prevent every miscarriage or identify every genetic condition. Patients should understand these limitations before deciding whether to proceed.
PGT-M testing in India is used to investigate a specific inherited condition associated with a known disease-causing genetic variant. It may be considered when a family has a confirmed genetic diagnosis that presents a reproductive risk.
Examples of conditions that may be assessed through PGT-M include thalassaemia, sickle cell disease, spinal muscular atrophy and certain other inherited disorders. Whether a particular condition can be tested depends on the genetic findings and the laboratory's capabilities.
Before treatment, the specialist may request genetic reports from the prospective parents or an affected family member. The laboratory may need to develop or validate a testing strategy for the specific variant.
This preparation can take additional time, so patients should ask about the timeline before starting IVF.
PGT-M can reduce the risk of transmitting the specific condition being tested, but it cannot eliminate every possible genetic risk. Genetic counselling and discussion of prenatal confirmation remain important.
PGT-SR is used when one or both prospective parents carry certain structural chromosome rearrangements. These can include translocations, in which chromosome segments change position.
A carrier may be healthy but have an increased chance of producing embryos with an unbalanced chromosome structure. PGT-SR can help assess embryos for the targeted abnormality.
The result depends on the specific rearrangement and the laboratory's testing method. A chromosome analysis may be needed before the fertility team can recommend an appropriate approach.
Preimplantation genetic testing eligibility depends on the clinical reason for testing, medical history, genetic findings and availability of suitable embryos.
Patients who may be considered include:
Age alone does not automatically make someone eligible for every type of PGT.
Patients do not necessarily need to have infertility to consider PGT-M or PGT-SR. However, because PGT is performed on embryos created through IVF, an IVF cycle is required.
Before recommending testing, a fertility specialist may review previous IVF reports, genetic investigations, chromosome analysis, pregnancy history and relevant family medical records. Not every patient requires all these investigations.
The specialist should explain why the test is appropriate, what it can identify and what the possible results could mean for treatment.
The PGT testing in India process involves several stages. The total time depends on the IVF protocol, embryo development, type of genetic test and laboratory turnaround time.
The fertility specialist reviews the patient's medical history, previous treatment and reason for considering genetic testing. Genetic counselling may be recommended, particularly when an inherited condition is involved.
Medication stimulates the ovaries to develop follicles. The doctor monitors the response and collects the eggs when they are ready.
The number of eggs retrieved varies according to ovarian reserve, age and individual response to medication.
The eggs are fertilised in the laboratory using an appropriate IVF method. ICSI may be used when clinically indicated.
Embryos are monitored as they develop. Not every fertilised egg reaches the blastocyst stage, when biopsy is commonly performed.
A trained embryologist collects a small sample of cells from the outer layer of a suitable blastocyst. The sample is sent for genetic analysis.
Although biopsy is commonly performed, there is a possibility of embryo damage. The clinic should explain its laboratory procedures and how samples are handled.
The laboratory performs the selected test. PGT-A examines chromosome number, PGT-M checks for a specific inherited variant, and PGT-SR assesses the targeted structural chromosome abnormality.
Results may be inconclusive, and some findings require additional interpretation.
Embryos are commonly frozen while the genetic results are awaited. Once the results are available, the fertility specialist discusses whether an embryo is suitable for consideration for transfer.
A suitable result does not guarantee a successful pregnancy. If no embryo is suitable, the doctor can discuss the available alternatives.
The timeline varies between patients and laboratories.
| Treatment stage | Typical timing or consideration |
|---|---|
| Fertility consultation | Depends on appointment availability and existing reports |
| Genetic test preparation | May take additional time, especially for PGT-M |
| Ovarian stimulation | Often around 10–14 days, depending on the protocol |
| Embryo development | Commonly five to seven days after fertilisation for embryos reaching the blastocyst stage |
| Genetic analysis | Depends on the laboratory and test type |
| Frozen embryo transfer | Planned after results and medical assessment |
These are general estimates, not guaranteed timelines. Patients should ask whether specialised genetic preparation, embryo freezing and transfer are included in the clinic's treatment schedule.
The cost of PGT testing in India depends on the type of test, the IVF procedure, the number of embryos tested and the laboratory's charges. PGT-M may involve additional preparation because the test needs to target a particular inherited genetic variant.
The total treatment cost may include:
| Cost component | What affects the cost |
|---|---|
| Consultation and investigations | Medical history and tests required |
| IVF or ICSI | Treatment protocol and laboratory services |
| Fertility medication | Dosage and duration |
| Embryo biopsy | Laboratory procedure and number of embryos |
| Genetic testing | PGT-A, PGT-M or PGT-SR and the number of samples |
| Embryo freezing and storage | Freezing procedure and storage duration |
| Frozen embryo transfer | Medication, monitoring and transfer charges |
| Additional genetic services | Counselling or specialised test preparation |
Resource: Request a written estimate directly from the selected hospital and genetic laboratory. Confirm whether the quotation covers IVF, biopsy, genetic analysis, embryo freezing, storage and transfer.
Before confirming treatment, ask the hospital:
Compare complete quotations rather than choosing a hospital on the basis of its starting price.
Price disclaimer: Any price information used in this article is based on previous-year data and should be treated as indicative. Actual charges may change according to the hospital, laboratory and treatment plan. For exact and updated pricing, call or email Healthroop or request a written quotation from the selected hospital before starting treatment.
The benefits depend on the type of test and the medical reason for using it.
These benefits must be weighed against the cost, biopsy risks, possibility of inconclusive results and chance that no embryo will be suitable for transfer.
PGT has important limitations that patients should understand before treatment.
PGT also does not replace prenatal screening or diagnostic testing. Patients should discuss the appropriate options with their fertility specialist and obstetrician if pregnancy occurs.
When comparing hospitals, confirm that the centre can provide the specific IVF and genetic testing services required for your case.
Healthroop's hospital directory can be used as a starting point for enquiries. Its listings include hospitals with fertility and IVF services, but patients should confirm PGT availability directly with the relevant branch.
Hospitals to enquire with include:
These are options for further enquiry, not a ranking of PGT providers. Availability may vary by location.
Before selecting a hospital, ask about the embryology team's experience, laboratory arrangements, result turnaround time, handling of inconclusive results, embryo storage and the complete treatment cost.
Healthroop helps patients explore fertility treatment options in India by connecting them with relevant hospitals and assisting with treatment enquiries. If you are considering PGT-A, PGT-M or PGT-SR, Healthroop can help you enquire about hospitals offering IVF services, arrange consultations where available and request treatment estimates. The final decision about genetic testing, eligibility and embryo transfer rests with the treating fertility specialist after reviewing your medical history and genetic reports.
Healthroop can assist you with:
To enquire about hospitals and PGT treatment options, visit Healthroop's contact page and share your medical requirements.
PGT testing in India can be useful for prospective parents who need information about a known inherited condition, a chromosome rearrangement or another specific genetic concern. PGT-A, PGT-M and PGT-SR have different purposes, so the right test depends on the patient's medical findings.
Before proceeding, discuss the benefits and limitations with a fertility specialist, ask whether genetic counselling is needed and obtain a written breakdown of the full treatment cost. PGT can support reproductive decision-making, but it cannot guarantee pregnancy or eliminate every genetic risk.
Answers on PGT testing types, eligibility, cost, and planning care in India.
PGT testing in India examines selected genetic features of embryos created through IVF before embryo transfer. Depending on the clinical concern, it can assess chromosome number, a specific inherited genetic condition or a structural chromosome rearrangement. The appropriate test depends on medical history and specialist advice.
PGT-A assesses chromosome number and looks for extra or missing chromosomes. PGT-M tests for a specific disease-causing genetic variant associated with an inherited condition. The two tests serve different purposes, and the choice depends on the patient's genetic findings and reproductive goals.
Eligibility depends on the medical reason for testing, genetic findings and reproductive history. PGT may be considered for people with a known inherited condition or chromosome rearrangement. A fertility specialist and genetic counsellor can explain whether testing is appropriate and what the results may mean.
No. PGT is not required for every IVF cycle. It may be considered when a specific genetic concern needs investigation. Routine PGT-A has not been shown to improve live-birth outcomes for all IVF patients, so the decision should be based on individual circumstances.
The timeline depends on IVF treatment, embryo development, laboratory procedures and the type of test. Embryos are commonly frozen while results are awaited. PGT-M may require additional preparation before IVF, so patients should request a personalised schedule from their fertility centre.
The cost varies according to the test type, IVF procedure, number of embryos tested, laboratory charges and embryo storage. Request an itemised quotation that explains which services are included and whether biopsy, genetic analysis, freezing, storage and embryo transfer are charged separately.
No. PGT examines specific genetic features and cannot detect every genetic condition or developmental problem. Results can also be inaccurate or inconclusive. Even when an embryo has a reassuring result, implantation failure, miscarriage and other pregnancy complications remain possible.
PGT-A does not guarantee a higher IVF success rate. Evidence has not established that routine use improves the overall chance of a live birth for every IVF patient. Its potential value depends on the clinical situation, and testing may reduce the number of embryos available for transfer.
PGT-M can reduce the risk of transmitting a specific inherited condition when the relevant genetic variant is known and the test can identify it reliably. However, it cannot eliminate every genetic risk. Genetic counselling and discussion of prenatal confirmation are important parts of treatment planning.
Look for a centre with appropriate fertility expertise, trained embryologists and access to a qualified genetic testing laboratory. Confirm that it offers the specific test required, explains uncertain results and provides a written estimate covering the full treatment process.